Clinical trial
Effect of Oral Phloroglucin (Flospan®) as Premedication of Non-sedative Diagnostic Esophagogastroduodenoscopy: Single Center, Prospective, Double Blinded, Randomized Controlled Trial
NCT03342118 is registered in ClinicalTrials.gov with Keimyung University Dongsan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Oral Phloroglucin (Flospan®) as Premedication of Non-sedative Diagnostic Esophagogastroduodenoscopy: Single Center, Prospective, Double Blinded, Randomized Controlled Trial
- Lead sponsor
- Keimyung University Dongsan Medical Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 21, 2017
- Completion date
- December 29, 2017
- Enrollment
- 140 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anti-spasmodics, gastric peristalsis, non-sedative endoscopy